Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Viemed HealthcareVMD -3.16%93 Receivables Turnover is 2.66 as of Mar. 2026. GuruFocus rates VMD with a GF Score™ of 93/100 and a GF Value™ of $10.93 (Fairly Valued). The stock has 7 warning signs investors should review. Among 812 Medical Devices & Instruments companies, Viemed Healthcare ranks better than 88.3% on this metric.
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Viemed Healthcare's Revenue for the
three
months ended in Mar. 2026 was $75.4 Mil. Viemed Healthcare's average Accounts Receivable for the
three
months ended in Mar. 2026 was $28.4 Mil.
Hence, Viemed Healthcare's Receivables Turnover for the
three
months ended in Mar. 2026 was 2.66.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Viemed Healthcare Receivables Turnover Related Terms
Viemed Healthcare Receivables Turnover Historical Data
* Premium members only.
The historical data trend for Viemed Healthcare's Receivables Turnover can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
VMD vs DCTH, VREX, SI: Receivables Turnover Comparison
For the Medical Devices subindustry, Viemed Healthcare's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Viemed Healthcare Receivables Turnover vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Viemed Healthcare's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Viemed Healthcare's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Viemed Healthcare (VMD) has a Receivables Turnover of 2.66 as of Mar. 2026. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Viemed Healthcare and its competitors. According to the industry distribution chart, Viemed Healthcare ranks #95 out of 812 companies in the Medical Devices & Instruments industry, placing it in the top 11.7%.
Is Viemed Healthcare's Receivables Turnover too high?
Viemed Healthcare's current Receivables Turnover is 2.66. The Medical Devices & Instruments industry median Receivables Turnover is 5.51. Viemed Healthcare's value of 2.66 is 51.7% below this industry median. Based on the distribution chart, Viemed Healthcare ranks #95 out of 812 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Viemed Healthcare has a GF Score™ of 93/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Viemed Healthcare's Receivables Turnover compare to DCTH and VREX?
According to the Medical Devices & Instruments industry distribution chart, Viemed Healthcare ranks #95 out of 812 companies for Receivables Turnover. This places Viemed Healthcare in the top 12% of its industry — outperforming the majority of peers. The industry median Receivables Turnover is 5.51. Viemed Healthcare's value of 2.66 is 51.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Receivables Turnover for a Medical Devices & Instruments company?
The median Receivables Turnover among Medical Devices & Instruments companies is 5.51, based on 812 companies in the industry. Companies in the top quartile (top 25%) have a Receivables Turnover significantly above this median, while those in the bottom quartile fall well below. However, Receivables Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Viemed Healthcare's current Receivables Turnover of 2.66 is 51.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Receivables Turnover mean?
A high Receivables Turnover can signal that a stock is expensive relative to its fundamentals. The accounts receivables turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by Average Accounts Receivable. View historical data on Viemed Healthcare and its competitors. For the Medical Devices & Instruments industry, the median Receivables Turnover is 5.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Viemed Healthcare's current Receivables Turnover is 2.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Viemed Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Viemed Healthcare (VMD) is currently considered Fairly Valued. The stock's GF Value™ is $10.93, compared to a current price of $11.94 — trading 9.2% above its estimated fair value. The current Receivables Turnover is 2.66 and 51.7% below the Medical Devices & Instruments industry median of 5.51. Viemed Healthcare's overall GF Score™ is 93/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Receivables Turnover calculated?
Receivables Turnover is calculated from a company's financial statements. For Viemed Healthcare (VMD), the current Receivables Turnover is 2.66 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Viemed Healthcare (VMD) Overvalued in 2026?
Based on GuruFocus' analysis, Viemed Healthcare stock appears to be overvalued.
The current stock price of $11.94 is trading 9.2% above its estimated GF Value™ of $10.93.
GuruFocus considers Viemed Healthcare to be Fairly Valued.
Key valuation signals for VMD:
Receivables Turnover: 2.66
GF Value™: $10.93 vs. price of $11.94 (9.2% above fair value)
Industry Position: 51.7% below the Medical Devices & Instruments median (#95 of 812)
No single metric tells the full story. See the VMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Viemed Healthcare Inc is a provider of home medical equipment ("HME") and post-acute healthcare services in the United States, with a focus on respiratory, chronic care, and women's health products and services. The Company's primary service offerings focus on effective in-home treatment, with clinical practitioners providing therapy and counseling to patients in their homes using cutting-edge technology. The company generates the majority of its revenue from medical equipment rental, sales, and supply.
93GF Score
Get the complete analysis for VMD
Receivables Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VMD has been successfully added to your 
